ASTH (NASDAQ: ASTH) reported Q3 EPS of $0.01, $0.46 worse than the analyst estimate of $0.47. Revenue for the quarter came in at $956 million versus the consensus estimate of $952.86 million.

GUIDANCE:

ASTH sees FY2025 revenue of $3.1-3.18 billion, versus the consensus of $3.21 billion.

For earnings history and earnings-related data on ASTH (ASTH) click here.